Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
La Revue De Medecine Interne
|
October 16, 2002
[Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ]
O Decaux, C Cazalets-Lacoste, B Cador-Rousseau, et al.
Pathologie-Biologie
|
December 1, 1987
[Value of computer processing of data acquired by cytofluorometry for biological analyses]
G Merdrignac-Lenoan, J P le Pichon, P Pellen, et al.
La Revue De Medecine Interne
|
May 7, 2013
[100 essential drugs. An internal medicine approach]
M Thomas, P Arlet, O Aumaitre, et al.
Pathologie-Biologie
|
August 31, 2015
Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients
M-P Beaumont-Epinette, C Moreau, S Besnard, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Leukemia Research
|
December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology
J E Goasguen, M Zandecki, C Mathiot, et al.
European Journal of Haematology
|
January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)
O Mejjad, X Le Loët, J P Basuyau, et al.
The European Journal of Medicine
|
October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)
A Daragon, C Humez, C Michot, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne
|
January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]
C Mathiot, B Grosbois, J L Teillaud, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
La Revue De Medecine Interne
|
October 16, 2002
[Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ]
O Decaux, C Cazalets-Lacoste, B Cador-Rousseau, et al.
Pathologie-Biologie
|
December 1, 1987
[Value of computer processing of data acquired by cytofluorometry for biological analyses]
G Merdrignac-Lenoan, J P le Pichon, P Pellen, et al.
La Revue De Medecine Interne
|
May 7, 2013
[100 essential drugs. An internal medicine approach]
M Thomas, P Arlet, O Aumaitre, et al.
Pathologie-Biologie
|
August 31, 2015
Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients
M-P Beaumont-Epinette, C Moreau, S Besnard, et al.
Journal of Clinical Immunology
|
January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
C Mathiot, J L Teillaud, M Elmalek, et al.
Leukemia Research
|
December 29, 1999
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology
J E Goasguen, M Zandecki, C Mathiot, et al.
European Journal of Haematology
|
January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)
O Mejjad, X Le Loët, J P Basuyau, et al.
The European Journal of Medicine
|
October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)
A Daragon, C Humez, C Michot, et al.
American Journal of Hematology
|
February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)
T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne
|
January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]
C Mathiot, B Grosbois, J L Teillaud, et al.
Page
of 8